~340 spots leftby Mar 2027

LET + ACL Reconstruction for Knee Injuries

(STABILITY LTF Trial)

Recruiting at 7 trial locations
Age: < 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Western University, Canada
No Placebo Group

Trial Summary

What is the purpose of this trial?

From 2014-2017, across 7 Canadian and 2 European sites, we randomized 618 patients at high-risk of re-injury, to anterior cruciate ligament reconstruction (ACLR) with or without a lateral extraarticular tenodesis (LET) and demonstrated that the addition of the LET reduced the risk of instability (RRR=0.38; 95% Confidence Interval (CI), 0.21-0.52; P=0.0001) and graft re-rupture (RRR, 0.67; 95% CI, 0.36-0.83; P=0.001). As a result, practice has changed; there has been a large increase in the proportion of orthopaedic surgeons recommending the addition of an LET at the time of ACLR and an increase in the number of patients requesting an LET from their surgeon. There is some weak evidence suggesting that in the longer term, the LET may increase the risk of developing osteoarthritis (OA) in that knee. Knee OA affects over 4.4 million Canadians and the number of younger adults being diagnosed with knee OA is growing and is a primary reason for seeking healthcare in Canada. The impact of OA in Canada is enormous and projected to cost Canada $17.5 billion annually in lost productivity alone by 2031. This study will use imaging and patient-reported Knee Outcomes Osteoarthritis Score (KOOS) to evaluate the incidence of OA at 10-years post ACL reconstruction with and without LET. We will also collect information about overall knee health, patient-reported outcomes, costs associated with knee injury, rehabilitation and disability, clinical failure, functional ability, and sport participation. It is crucial that we understand the risks of developing knee OA associated with the addition of an LET to an ACLR so that surgeons and patients can make informed decisions, not just for their immediate post injury treatment of the failed ligament, but for the potential long-term consequences of that decision.

Eligibility Criteria

This trial is for individuals aged up to 25 with an ACL deficient knee, who play competitive pivoting sports and have a significant pivot shift in the knee or general ligament laxity. It's not suitable for those outside of these criteria.

Inclusion Criteria

My knee is unstable when it rotates.
I am between the ages when my bones have stopped growing and 25 years old.
My knee lacks a functioning ACL.
See 2 more

Treatment Details

Interventions

  • ACL Reconstruction (Procedure)
  • Lateral Extra-Articular Tenodesis (LET) (Procedure)
Trial OverviewThe study examines long-term effects of adding Lateral Extra-Articular Tenodesis (LET) to Anterior Cruciate Ligament Reconstruction (ACLR). It aims to determine if LET increases the risk of developing osteoarthritis over a decade.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: ACL + LETExperimental Treatment2 Interventions
Anatomic ACL reconstruction following the same procedure as the active comparator group with an added lateral extra-articular tenodesis (LET).
Group II: ACL ReconstructionActive Control1 Intervention
Standard ACL reconstruction only.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Western University, Canada

Lead Sponsor

Trials
270
Recruited
62,500+

Canadian Institutes of Health Research (CIHR)

Collaborator

Trials
1,417
Recruited
26,550,000+